REBECCA DEITZER: Open Payments
NPI 1396006425 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 16 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,125 · 2025 $1,795
Food & beverage: $1,712Education: $83
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $236 |
| GENZYME CORPORATION | 1 | $150 |
| Pharmacosmos Therapeutics Inc. | 1 | $145 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Incyte Corporation | 1 | $126 |
| Genentech USA, Inc. | 1 | $126 |
| Amgen Inc. | 1 | $125 |
| Grifols USA, LLC | 1 | $125 |
| Syndax Pharmaceuticals, Inc. | 1 | $120 |
| Corcept Therapeutics | 1 | $115 |
Products named: MONOFERRIC, GIVLAARI, Niktimvo, Xolair, KRYSTEXXA, Vanflyta, Prolastin-C Liquid, Korlym.
Industry payments across NY — which companies pay providers there.
